Global Vessel Sealing Devices Market to Reach USD 6.1 Billion by 2034

Introduction

Straits Research has published a comprehensive market intelligence report revealing that the global vessel sealing devices market is experiencing robust growth driven by expanding surgical procedure volumes, rising adoption of minimally invasive and robotic-assisted surgeries, and greater emphasis on patient safety and operational efficiency.

According to the report, the vessel sealing devices market was valued at USD 3.2 billion in 2025 and is forecast to expand to USD 6.1 billion by 2034, driven by a 7.4% CAGR during the 2026–2034 period.

The report also highlights the increasing penetration of energy-based vessel sealing technologies, including bipolar, ultrasonic, and hybrid systems across open, laparoscopic, and robotic-assisted procedures. These devices play a critical role in achieving secure hemostasis, reducing operative time, and lowering complications associated with bleeding.

Strategic Outlook

The growing shift toward outpatient surgical settings, including ambulatory surgical centers, and ongoing investments in surgical infrastructure present significant opportunities for medical device manufacturers and healthcare providers. Integration with robotic platforms and innovations in energy technology continue to be key areas of competitive differentiation.

Key Market Highlights

• Laparoscopic procedures led the market, with approximately USD 1.9 billion in revenue, supported by preference for minimally invasive techniques that improve recovery outcomes.
• General surgery applications contributed around USD 1.4 billion, representing the largest application segment globally.
• Hospitals remained the dominant end-user, accounting for USD 2.1 billion in market value due to high surgical volumes and advanced infrastructure.
• North America emerged as the most mature regional market, with the United States alone contributing roughly USD 1.2 billion in 2025.

The report also highlights the increasing penetration of energy-based vessel sealing technologies, including bipolar, ultrasonic, and hybrid systems, across open, laparoscopic, and robotic-assisted procedures. These devices play a critical role in achieving secure hemostasis, reducing operative time, and lowering complications associated with bleeding.

Competitive Players

1. Medtronic plc
2. Johnson & Johnson
3. Olympus Corporation
4. Braun Melsungen AG
5. ConMed Corporation
6. Stryker Corporation
7. Smith & Nephew plc
8. Karl Storz SE & Co. KG
9. Intuitive Surgical, Inc.
10. Zimmer Biomet Holdings, Inc.
11. Boston Scientific Corporation
12. Applied Medical Resources Corporation
13. Microline Surgical
14. KLS Martin Group
15. Erbe Elektromedizin GmbH

Recent Developments

• August 2025: Medtronic plc enhanced its advanced bipolar vessel sealing platform to improve sealing consistency in laparoscopic surgery.
• September 2025: Johnson & Johnson expanded ultrasonic vessel sealing device availability across major hospital networks.

Segmentation